Event Panel Schedule

Michael H. Bison , Partner / Goodwin Procter LLP Info

Michael Bison is a partner in Goodwin’s nationally and internationally recognized Technology and Life Sciences practice group and a member of its Life Sciences and Capital Markets practices. He represents privately held and publicly traded companies… [show more]

Michael Bison is a partner in Goodwin’s nationally and internationally recognized Technology and Life Sciences practice group and a member of its Life Sciences and Capital Markets practices. He represents privately held and publicly traded companies with a strong emphasis on companies across the spectrum of the life sciences industry, including biotechnology, medical devices, diagnostics and healthcare information technology. Mr. Bison also regularly represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments, exits and secondary stock sale transactions, as well as underwriters focused on the life sciences industry in connection with capital market and M&A transactions. Mr. Bison typically serves as outside general counsel to his clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including company formation and founder issues, venture capital and growth equity financings, public offerings, M&A, strategic collaborations, commercial transactions, corporate governance and general corporate matters. He is regularly recognized by his clients for his extensive industry knowledge and for providing practical, result-oriented legal advice. Mr. Bison has advised numerous international companies with respect to their U.S. listings, capital markets transactions, strategic collaborations and M&A transactions, as well as with respect to the establishment of U.S. subsidiaries and various operational matters with respect to these subsidiaries. Mr. Bison’s work has been recognized by several industry publications, including the Best Lawyers in America, LMG Life Sciences, Who's Who Legal, The Legal 500, Law & Politics magazine, and Boston magazine. [hide]

Joseph Oakenfold , Vice President / Deutsche Bank AG Info

Joe Oakenfold is the lead salesperson for Deutsche Banks‘ Depositary Receipts business in Europe bringing corporate issuers to the US capital markets and enabling access to the worlds’ largest pool of investment. With over 20 years’ experience, Joe… [show more]

Joe Oakenfold is the lead salesperson for Deutsche Banks‘ Depositary Receipts business in Europe bringing corporate issuers to the US capital markets and enabling access to the worlds’ largest pool of investment. With over 20 years’ experience, Joe has covered Depositary Receipt roles from Investor Relations and Trading to Product Management and Corporate Sales. Joe has lived and worked in Europe and Asia but also assisted corporates from Latin America, Central and Eastern Europe and the Middle East and Africa to list on US and European exchanges. In the Life Sciences, MedTech and Pharma space, Joe has helped a host of clients including Philips, Smith&Nephew, Chi-Med, Daiichi-Sankyo, Genmab, Ipsen, Lundbeck, TiGenix and Bavarian Nordic access US investors through the Deutsche Bank Depositary Receipt platform. Joe is a member of the UK IR society with a Certificate in Investor Relations and Securities Institute qualifications. His career CV includes Deutsche Bank, BNY Mellon, Macquarie and RBC. [hide]

Patrick Hughes , Director / Nasdaq Info

Patrick has over 15 years of experience working with IR teams in various advisory capacities. Prior to joining Nasdaq, he held financial communication roles at Citigate Dewe Rogerson and at Burson-Marsteller.

Jenny Harper , Partner / PricewaterhouseCoopers Info

I am a Capital Markets & Accounting Advisory partner at PwC with over 20 years of experience on US IPOs, cross-border M&A, and private or public US debt/equity offerings, where I advise companies on transaction readiness, the listing process… [show more]

I am a Capital Markets & Accounting Advisory partner at PwC with over 20 years of experience on US IPOs, cross-border M&A, and private or public US debt/equity offerings, where I advise companies on transaction readiness, the listing process, navigating SEC regulation, due diligence and transaction related accounting and reporting matters such as IFRS/US GAAP conversions, pro forma information, carve-out financial statements, and SEC comment letters. Based in London for over 15 years, I work with a mix of public and private companies across a variety of industries and have advised on a number of recent or ongoing cross-border M&A deals and US IPOs involving UK and European companies. [hide]